National Drug Schedules

NOTE - Effective December 19, 2013, Schedule F to the Food and Drug Regulationswas repealed and replaced by a list of prescription drugs, called the Prescription Drug List. Therefore, all entries in the National Drug Schedules (NDS) whose footnote indicates that they appear in Schedule F (F1/F2) should now be considered part of the Prescription Drug List (PDL).

Entries whose footnote indicates that they are "Schedule F Recommended" (FR) should now be considered recommended for addition to the PDL. Some of the "Schedule F Recommended" entries may have been added or will shortly be added to the PDL by Health Canada, but either way these entries will continue to be listed in Schedule I of the NDS.

For more information on the Prescription Drug List, please consult the Health Canada website.

Drug Product Database
Licensed Natural Health Products Database

Print Friendly Export to CSV

Drug Name	Comment	Schedule	Date
Tacrolimus and its derivatives^F1		I	SEP / 98
Talbutal^C2		I	JUN / 02
Taliglucerase alfa^PDL		I	JUL / 14
Tamoxifen and its salts^F1		I	SEP / 98
Tamsulosin and its salts^F1		I	SEP / 99
Tapentadol^N	(3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-phenol), its salts, derivatives and isomers and salts of derivatives and isomers	I	JAN / 16
Tazarotene^F1		I	SEP / 98
Tazobactam and its salts and derivatives^F1		I	SEP / 98
Tedizolid or its salts or derivatives^PDL	including but not limited to Tedizolid phosphate	I	MAY / 15
Teduglutide^PDL		I	OCT / 15
Tegafur and its salts^F1		I	JUL / 03
Tegaserod and its salts^F1		I	MAY / 04
Telaprevir or its derivatives^PDL		I	DEC / 13
Telbivudine^F1		I	MAY / 09
Telmisartan and its salts and derivatives^F1		I	MAR / 01
Telotristat or its salts or derivatives^PDL		I	NOV / 18
Temazepam and its salts^TS		I	SEP / 98
Temozolomide and its salts^F1		I	MAR / 01
Teniposide^F1		I	SEP / 98
Tenofovir or its salts or derivatives^PDL	Including but not limited to: tenofovir disoproxil, tenofovir alafenamide	I	DEC / 13
Tenoxicam and its salts^F1		I	SEP / 98
Terazosin and its salts^F1		I	SEP / 98
Terbinafine and its salts^F1		I	SEP / 98
Terbutaline and its salts^F1		I	SEP / 98
Terconazole and its salts^F1		I	SEP / 98
Terfenadine and its salts^F1		I	SEP / 98
Teriparatide and its salts^F1		I	APR / 07
Terlipressin and its salts^F1		I	SEP / 98
Tesamorelin or its salts or derivatives^PDL		I	MAY / 14
Testosterone^C3		I	JUN / 02
Tetanus immune globulin		I	FEB / 02
Tetanus toxoid		II	DEC / 98
Tetrabenazine and its salts^F1		I	SEP / 98
Tetracaine^PDL	when in a preparation containing an equal amount of lidocaine and recommended for topical use on the skin, in concentrations of 7% or higher	I	FEB / 14
Tetracaine and its salts	for ophthalmic or parenteral use	II	SEP / 98
Tetracaine and its salts	for topical use on mucous membranes, except lozenges	III	SEP / 98
Tetracycline or its salts or derivatives^PDL		I	DEC / 18
Tetrahydrozoline	in nasal preparations for pediatric use	II	SEP / 98
Tetrahydrozoline.	for ophthalmic use and in nasal preparations for adults	U
Tetrazepam^TS		I	JUN / 02
Tezacaftor or its salts^PDL		I	JUL / 18
Thalidomide^F1		I	SEP / 98
Thebacon^N		I	JUN / 02
Thebaine (paramorphine)^N		I	JUN / 02
Theophylline and its salts^F1		I	SEP / 98
Thiabendazole^F2		I	SEP / 98
Thialbarbital^C2		I	JUN / 02
Thiamylal^C2		I	JUN / 02
Thiethylperazine and its salts^F1		I	SEP / 98
Thiobarbituric Acid^C2		I	JUN / 02
Thiocarlide^F1		I	SEP / 98
Thiofentanyl^N		I	JUN / 02
Thioguanine^F1		I	SEP / 98
Thiopental^C2		I	JUN / 02
Thiopropazate and its salts^F1		I	SEP / 98
Thioproperazine and its salts^F1		I	SEP / 98
Thioridazine and its salts^F1		I	SEP / 98
Thiotepa^F1		I	SEP / 98
Thiothixene and its salts^F1		I	SEP / 98
Thiouracil and its derivatives^F1		I	SEP / 98
Thrombin		II	SEP / 98
Thyroglobulin		II	SEP / 98
Thyroid^F2		I	SEP / 98
Thyrotropin		II	SEP / 98
Thyrotropin alfa^F1		I	MAY / 04
Thyroxin and its salts^F1		I	SEP / 98
Tiamulin or its salts^PDL	For veterinary use, including but not limited to: Tiamulin fumarate	I	DEC / 18
Tiaprofenic acid and its salts^F1		I	SEP / 98
Tibolone^C3		I	JUN / 02
Ticagrelor or its derivatives^PDL		I	DEC / 13
Ticlopidine and its salts^F1		I	SEP / 98
Tigecycline^F1		I	APR / 08
Tilidine and its salts, derivatives and salts of derivatives^N		I	JUN / 02
Tiludronic acid and its salts^F1		I	SEP / 98
Timolol and its salts^F1		I	SEP / 98
Tinidazole^F1		I	SEP / 98
Tinzaparin and its salts^F1		I	SEP / 98
Tioconazole and its salts^F1	except in preparations for topical or vaginal use in humans	I	SEP / 98
Tioconazole and its salts.^F2		I	SEP / 98
Tioconazole and its salts..	in preparations for intra-vaginal use	III	OCT / 98
Tioconazole and its salts...	in preparations for topical use	U	OCT / 98
Tiomesterone^C3		I	JUN / 02
Tiotropium bromide^F1		I	MAY / 04
Tipiracil or its salts^PDL		I	MAR / 18
Tipranavir and its salts^F1		I	FEB / 07
Tirofiban and its salts and derivatives^F1		I	MAR / 01
Tisagenlecleucel^PDL		I	OCT / 18
Tizanidine and its salts^F1		I	SEP / 99
Tobramycin and its salts and derivatives^F1		I	SEP / 98
Tocainide and its salts^F1		I	SEP / 98
Tocilizumab^FR		I	APR / 10
Tofacitinib or its salts^PDL		I	MAY / 14
Tolazamide^F1		I	SEP / 98
Tolazoline and its salts^F1		I	SEP / 98
Tolbutamide^F1		I	SEP / 98
Tolcapone^F1		I	SEP / 99
Tolfenamic acid and its salts and derivatives^F1		I	MAY / 04
Tolmetin and its salts^F1		I	SEP / 98
Tolterodine and its salts^F1		I	SEP / 99
Tolvaptan or its derivatives^PDL		I	DEC / 13

153 result(s)

Print Friendly Export to CSV

Footnotes

C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
C4: drug is in the Controlled Drugs and Substances Act
C5: drug is in the Regulations Under CDSA
CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
NR: drug has not been reviewed by NDSAC
PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
U: drug has been reviewed by NDSAC and is unscheduled

National Drug Schedules

Search: National Drug Schedules

153 result(s)

Footnotes